Clinical Trial Update: Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic Areas [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP malaria vaccines in malaria-endemic areas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• AdCh63 ME-TRAP (AdCh63 ME-TRAP)
• MVA ME-TRAP (MVA ME-TRAP)

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1 | Status: COMPLETED